Literature DB >> 1475235

Kinetics and mechanism of degradation of Zileuton, a potent 5-lipoxygenase inhibitor.

F J Alvarez1, R T Slade.   

Abstract

Zileuton (N-(1-benzo[b]thien-2-ylethyl)N-hydroxyurea) is a powerful 5-lipoxygenase inhibitor. The chemical degradation of Zileuton and related hydroxyurea derivatives was studied in aqueous solutions as a function of pH and temperature. The pH profile for the degradation of Zileuton shows an acid-catalyzed region at pH values below 2, water hydrolysis of the protonated form at pH values from 3 to 8, and water hydrolysis of the unprotonated form at pH values greater than 9. Hydrolysis of the hydroxyurea moiety to give the hydroxylamine derivative represents the main degradation pathway for Zileuton. This product, however, is not stable and is present at low concentrations at pH values below 6 and not observed at pH values greater than 7. Further decomposition of the hydroxylamine derivative leads to the observed degradation products. Air oxidation to the isomeric oximes accounts for the observed products at pH values greater than 7. Hydrolysis of the oximes to the ketone derivative accounts for the observed products at pH values 2 to 6. Parallel decomposition pathways to the alcohol derivative were noted under strongly acidic conditions, pH 0 to 2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475235     DOI: 10.1023/a:1015819115075

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Oxidation of aliphatic hydroxylamines in aqueous solutions.

Authors:  A H Beckett; A R Purkaystha; P H Morgan
Journal:  J Pharm Pharmacol       Date:  1977-01       Impact factor: 3.765

Review 2.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.

Authors:  J B Summers; B P Gunn; J G Martin; H Mazdiyasni; A O Stewart; P R Young; A M Goetze; J B Bouska; R D Dyer; D W Brooks
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

4.  Kinetics of hydrolysis of barbituric acid derivatives.

Authors:  E R Garrett; J T Bojarski; G J Yakatan
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

5.  Degradation of urea in concentrated aqueous solution.

Authors:  H L Welles; A R Giaquinto; R E Lindstrom
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

6.  Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.

Authors:  J B Summers; B P Gunn; J G Martin; M B Martin; H Mazdiyasni; A O Stewart; P R Young; J B Bouska; A M Goetze; R D Dyer
Journal:  J Med Chem       Date:  1988-10       Impact factor: 7.446

7.  In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase.

Authors:  J B Summers; B P Gunn; H Mazdiyasni; A M Goetze; P R Young; J B Bouska; R D Dyer; D W Brooks; G W Carter
Journal:  J Med Chem       Date:  1987-11       Impact factor: 7.446

8.  Hydroxamic acid inhibitors of 5-lipoxygenase.

Authors:  J B Summers; H Mazdiyasni; J H Holms; J D Ratajczyk; R D Dyer; G W Carter
Journal:  J Med Chem       Date:  1987-03       Impact factor: 7.446

  8 in total
  1 in total

1.  Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Todd D Williams; Nadezhda A Galeva; R Scott Obach; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-04-10       Impact factor: 3.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.